Close Menu

NEW YORK – Organ transplant diagnostics company CareDx announced today that it has formed a strategic partnership with NanoString Technologies to develop HistoMap, a gene expression profiling test to identify allograft rejection in transplant biopsy tissue.

Under the terms of the agreement, CareDx will combine its expertise and transplant registries with NanoString's nCounter platform, and its newly introduced Human Organ Transplant panel — a 770-gene panel designed to evaluate human immune response following organ transplantation.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new analysis suggests warming, not the arrival of humans, led to the extinction of the woolly rhinoceros thousands of years ago, the Economist reports.

Chinese health officials uncovered SARS-CoV-2 viral RNA on imported frozen food, but the New York Times reports catching COVID-19 that way would be unlikely.

The UK has ordered 60 million coronavirus vaccine doses from Novavax and 30 million doses from Janssen, according to the Guardian.

In Science this week: machine learning model predicts whether ion channel mutations will cause disease, and more.